Bissell MJ - Search Results

1

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.

Huang C, Park CC, Hilsenbeck SG, Ward R, Rimawi MF, Wang YC, Shou J, Bissell MJ, Osborne CK, Schiff R. Huang C, et al. Among authors: bissell mj. Breast Cancer Res. 2011 Aug 31;13(4):R84. doi: 10.1186/bcr2936. Breast Cancer Res. 2011. PMID: 21884573 Free PMC article.

2

Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Park CC, et al. Among authors: bissell mj. Cancer Res. 2008 Jun 1;68(11):4398-405. doi: 10.1158/0008-5472.CAN-07-6390. Cancer Res. 2008. PMID: 18519702 Free PMC article.

3

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.

Weigelt B, Lo AT, Park CC, Gray JW, Bissell MJ. Weigelt B, et al. Among authors: bissell mj. Breast Cancer Res Treat. 2010 Jul;122(1):35-43. doi: 10.1007/s10549-009-0502-2. Epub 2009 Aug 22. Breast Cancer Res Treat. 2010. PMID: 19701706 Free PMC article.

4

Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.

Nam JM, Onodera Y, Bissell MJ, Park CC. Nam JM, et al. Among authors: bissell mj. Cancer Res. 2010 Jul 1;70(13):5238-48. doi: 10.1158/0008-5472.CAN-09-2319. Epub 2010 Jun 1. Cancer Res. 2010. PMID: 20516121 Free PMC article.

5

Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ. Park CC, et al. Among authors: bissell mj. Cancer Res. 2006 Feb 1;66(3):1526-35. doi: 10.1158/0008-5472.CAN-05-3071. Cancer Res. 2006. PMID: 16452209 Free PMC article.

6

The influence of the microenvironment on the malignant phenotype.

Park CC, Bissell MJ, Barcellos-Hoff MH. Park CC, et al. Among authors: bissell mj. Mol Med Today. 2000 Aug;6(8):324-9. doi: 10.1016/s1357-4310(00)01756-1. Mol Med Today. 2000. PMID: 10904250 Review.

7

The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.

Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell MJ, Joffé EB, Simian M. Pontiggia O, et al. Among authors: bissell mj. Breast Cancer Res Treat. 2012 Jun;133(2):459-71. doi: 10.1007/s10549-011-1766-x. Epub 2011 Sep 21. Breast Cancer Res Treat. 2012. PMID: 21935603 Free PMC article.

8

β1 and β4 integrins: from breast development to clinical practice.

Nisticò P, Di Modugno F, Spada S, Bissell MJ. Nisticò P, et al. Among authors: bissell mj. Breast Cancer Res. 2014;16(5):459. doi: 10.1186/s13058-014-0459-x. Breast Cancer Res. 2014. PMID: 25606594 Free PMC article. Review.

9

Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.

Mirzoeva OK, Das D, Heiser LM, Bhattacharya S, Siwak D, Gendelman R, Bayani N, Wang NJ, Neve RM, Guan Y, Hu Z, Knight Z, Feiler HS, Gascard P, Parvin B, Spellman PT, Shokat KM, Wyrobek AJ, Bissell MJ, McCormick F, Kuo WL, Mills GB, Gray JW, Korn WM. Mirzoeva OK, et al. Among authors: bissell mj. Cancer Res. 2009 Jan 15;69(2):565-72. doi: 10.1158/0008-5472.CAN-08-3389. Cancer Res. 2009. PMID: 19147570 Free PMC article.

10

Homeostasis in the breast: it takes a village.

Rizki A, Bissell MJ. Rizki A, et al. Among authors: bissell mj. Cancer Cell. 2004 Jul;6(1):1-2. doi: 10.1016/j.ccr.2004.06.019. Cancer Cell. 2004. PMID: 15261134 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page